← Open Payments lookup

ANA URRIOLA: Open Payments

NPI 1235361106 · PATERSON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,341 in 72 payments from 16 companies in 2025. Trend: 2023 $1,417 · 2024 $1,665 · 2025 $1,341

Food & beverage: $1,341
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP13$240
Boehringer Ingelheim Pharmaceuticals, Inc.6$197
Novo Nordisk Inc11$183
GlaxoSmithKline, LLC.8$141
Kowa Pharmaceuticals America, Inc.7$109
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$98
Amgen Inc.4$63
Astellas Pharma US Inc3$58
ABBVIE INC.3$53
Madrigal Pharmaceuticals3$51

Products named: AIRSUPRA, JARDIANCE, Ozempic, TRELEGY ELLIPTA, ZORYVE, XIFAXAN, Veozah, REZDIFFRA.

Industry payments across NJ — which companies pay providers there.